Apologies - that was poorly written and done quickly on my phone.
Clinical trials has the Primary Outcome Measures as: 1) Overall Survival and 2) Leukemia-free survival - both with a 24 month time frame calculated from day of Bisantrene administrated.
The Estimated Primary Completion date was Sept 2021.... We can assume the last patient was treated approximately March 2020..
I know we all expect and hope the report to be provided soon, however if everything is going well is it possible that we don't get the results until Sept 2021 or March 2022? (in which case the longer the better)
Or do we expect an initial report from post administration checks even if Primary Outcome on a number of patients isn't recorded yet (fingers crossed)?
Cheers
-
- There are more pages in this discussion • 1,823 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.34 |
Change
-0.015(1.11%) |
Mkt cap ! $231.9M | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.36 | $1.31 | $132.3K | 98.59K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | $1.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.34 | 10069 | 2 |
View Market Depth
| Last trade - 15.54pm 20/06/2025 (20 minute delay) ? |
| RAC (ASX) Chart |